Edition:
United States

LivaNova PLC (LIVN.OQ)

LIVN.OQ on NASDAQ Stock Exchange Global Select Market

88.47USD
4:00pm EDT
Change (% chg)

$-0.07 (-0.08%)
Prev Close
$88.54
Open
$88.77
Day's High
$88.99
Day's Low
$88.25
Volume
83,463
Avg. Vol
146,600
52-wk High
$92.19
52-wk Low
$51.99

Select another date:

Thu, Mar 29 2018

BRIEF-Livanova Bicarbon Aortic Valves Receive CE Mark

* LIVANOVA BICARBON AORTIC VALVES RECEIVE CE MARK FOR EXPANDED USE LABELING WITH LOWER-DOSE BLOOD THINNERS IN LOW-RISK PATIENTS Source text for Eikon: Further company coverage:

BRIEF-Livanova Plc To Evaluate Treatment Outcomes For Novel Microburst Vns Therapy System

* LIVANOVA COMMENCES CLINICAL STUDY TO EVALUATE TREATMENT OUTCOMES FOR NOVEL MICROBURST VNS THERAPY SYSTEM Source text for Eikon: Further company coverage:

BRIEF-Livanova Announces Enrollment For PERFECT Perceval Valve Clinical Trial In China

* LIVANOVA ANNOUNCES ENROLLMENT FOR PERFECT PERCEVAL VALVE CLINICAL TRIAL IN CHINA

BRIEF-Microport Scientific Updates On Acquisition Of Business From Livanova PLC

* SELLER HAS AGREED TO SELL, CRM BUSINESS FOR AN INITIAL CONSIDERATION OF US$190 MILLION Source text for Eikon: Further company coverage:

BRIEF-Livanova Enters Agreement To Divest Cardiac Rhythm Management Business To Microport Scientific Corp

* LIVANOVA ENTERS INTO DEFINITIVE AGREEMENT TO DIVEST ITS CARDIAC RHYTHM MANAGEMENT BUSINESS FRANCHISE TO MICROPORT SCIENTIFIC CORPORATION

BRIEF-Livanova To Acquire Tandemlife

* LIVANOVA PLC - LIVANOVA HAS AGREED TO PAY UP TO $250 MILLION FOR TANDEMLIFE

BRIEF-Livanova Initiates Believe Aortic Heart Valve Study In The U.S., Canada

* LIVANOVA INITIATES BELIEVE AORTIC HEART VALVE STUDY IN THE U.S. AND CANADA

BRIEF-LivaNova Commences Global Restore-Life Study For Treatment-Resistant Depression

* LIVANOVA COMMENCES GLOBAL RESTORE-LIFE STUDY FOR TREATMENT-RESISTANT DEPRESSION Source text for Eikon: Further company coverage:

BRIEF-Livanova To Acquire Imthera Medical

* LIVANOVA PLC SAYS ENTERED INTO AN AGREEMENT TO ACQUIRE REMAINING OUTSTANDING INTERESTS IN IMTHERA MEDICAL, INC.

BRIEF-Microport Scientific's unit buys CRM business from Livanova

* ‍Unit buys CRM business for initial consideration of US$190 million​ from Livanova PLC Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Select another date: